Company Information
USD
4.61
- (0.7%)
NASDAQ:AMLX, AMYLYX PHARMACEUTICALS INC
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.
Address
43 Thorndike Street
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Ms. Karen Firestone
Director
Dr. George Mclean Milne, Jr
Chairman of the Board/Director
Mr. James M. Frates
CFO/Chief Accounting Officer
Ms. Daphne E. Quimi
Director
Mr. Paul Fonteyne
Director
Dr. Patrick Yeramian, M.D.
Chief Medical Officer
Mr. Joshua Cohen
Co-CEO/Director
Mr. Justin Klee
Co-CEO/Director
Ms. Margaret Olinger
Other Executive Officer
Ms. Gina M. Mazzariello
Chief Legal Officer/General Counsel
Ownership
Institution Holdings
Vanguard Group Inc
5,275,566 (7.783%)
BlackRock Inc
4,002,334 (5.905%)
Viking Global Investors LP
2,962,555 (4.371%)
Morgan Stanley - Brokerage Accounts
2,830,243 (4.176%)
Goldman Sachs Group Inc
2,513,722 (3.709%)
Stonepine Capital Management Llc
2,500,000 (3.688%)
Morningside Venture Investments Ltd.
2,313,227 (3.426%)
Millennium Management LLC
2,272,643 (3.353%)
BlackRock Fund Advisors
2,271,359 (3.351%)
Perceptive Advisors LLC
1,869,125 (2.758%)
Individual Holdings
Mr. Joshua Cohen
3,027,137 (4.466%)
Mr. Justin Klee
2,963,443 (4.372%)
Dr. George Mclean Milne, Jr
758,571 (1.120%)
Ms. Margaret Olinger
276,108 (0.409%)
Dr. Patrick Yeramian, M.D.
205,605 (0.304%)
Mr. James M. Frates
152,035 (0.224%)
Ms. Gina M. Mazzariello
82,912 (0.122%)
Ms. Karen Firestone
5,000 (0.007%)
Mr. Paul Fonteyne
3,947 (0.007%)
Funds Holdings
Vanguard Small Cap Index
1,465,390 (2.162%)
iShares Russell 2000 ETF
1,253,176 (1.849%)
Vanguard Small Cap Growth Index Fund
816,389 (1.204%)
Vanguard Institutional Extnd Mkt Idx Tr
599,820 (0.885%)
Fidelity Small Cap Index Fund
509,919 (0.752%)
Franklin Biotechnology Discovery Fund
446,592 (0.659%)
iShares Russell 2000 Growth ETF
445,437 (0.657%)
iShares Biotechnology ETF
383,861 (0.566%)
Fidelity Series Small Cap Opps Fd
373,400 (0.551%)
Principal SmallCap Growth Fund I
248,974 (0.367%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
